Herb–drug interactions between the medicinal mushrooms Lingzhi and Yunzhi and cytotoxic anticancer drugs: a systematic review
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1749-8546
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Herb–drug interactions between the medicinal mushrooms Lingzhi and Yunzhi and cytotoxic anticancer drugs: a systematic review ; volume:15 ; number:1 ; day:25 ; month:7 ; year:2020 ; pages:1-18 ; date:12.2020
Chinese medicine ; 15, Heft 1 (25.7.2020), 1-18, 12.2020
- Creator
-
Lam, Chun Sing
Cheng, Lok Pui
Zhou, Li Min
Cheung, Yin Ting
Zuo, Zhong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13020-020-00356-4
- URN
-
urn:nbn:de:101:1-2020092014075132908071
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lam, Chun Sing
- Cheng, Lok Pui
- Zhou, Li Min
- Cheung, Yin Ting
- Zuo, Zhong
- SpringerLink (Online service)
Other Objects (12)
Anticancer drug discovery from Chinese medicinal herbs
New anticancer drugs
Bisacylphosphane oxides as photo-latent cytotoxic agents and potential photo-latent anticancer drugs
Dihydroartemisinin is a hypoxia active anticancer drug that improves the cytotoxic action of radiotherapy
CDK7 inhibitors as anticancer drugs
Empagliflozin: a potential anticancer drug
Conditionally cytotoxic and drug-controllable non-cytotoxic rabies viruses
Cytotoxic drugs and the granulopoietic system
Medicinal mushrooms in adjuvant cancer therapies: an approach to anticancer effects and presumed mechanisms of action
Evaluation for pharmacokinetic exposure of cytotoxic anticancer drugs in elderly patients receiving (R-)CHOP therapy
Drug utilization evaluation of anticancer drugs in a charitable hospital
Neurological adverse reactions to anticancer drugs
Anticancer drug discovery from Chinese medicinal herbs
New anticancer drugs
Bisacylphosphane oxides as photo-latent cytotoxic agents and potential photo-latent anticancer drugs
Dihydroartemisinin is a hypoxia active anticancer drug that improves the cytotoxic action of radiotherapy
CDK7 inhibitors as anticancer drugs
Empagliflozin: a potential anticancer drug
Conditionally cytotoxic and drug-controllable non-cytotoxic rabies viruses
Cytotoxic drugs and the granulopoietic system
Medicinal mushrooms in adjuvant cancer therapies: an approach to anticancer effects and presumed mechanisms of action
Evaluation for pharmacokinetic exposure of cytotoxic anticancer drugs in elderly patients receiving (R-)CHOP therapy
Drug utilization evaluation of anticancer drugs in a charitable hospital
Neurological adverse reactions to anticancer drugs
Anticancer drug discovery from Chinese medicinal herbs
New anticancer drugs
Bisacylphosphane oxides as photo-latent cytotoxic agents and potential photo-latent anticancer drugs
Dihydroartemisinin is a hypoxia active anticancer drug that improves the cytotoxic action of radiotherapy
CDK7 inhibitors as anticancer drugs
Empagliflozin: a potential anticancer drug
Conditionally cytotoxic and drug-controllable non-cytotoxic rabies viruses
Cytotoxic drugs and the granulopoietic system
Medicinal mushrooms in adjuvant cancer therapies: an approach to anticancer effects and presumed mechanisms of action
Evaluation for pharmacokinetic exposure of cytotoxic anticancer drugs in elderly patients receiving (R-)CHOP therapy
Drug utilization evaluation of anticancer drugs in a charitable hospital